“At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccine in adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccin ...

On April 30, AstraZeneca admitted that the vaccine, sold under the name Vaxzevria, can cause fatal blood clots and low platelet counts, also known as thrombosis syndrome with thrombocytopenia ...

We readied to overcome a threat to vaccine trust Earlier this year, Vaxzevria, AstraZeneca's 'viral vector' COVID-19 vaccine, was battling perception issues, with stakeholders holding the ...

Patient safety is our highest priority. From the body of evidence in clinical trials and real-world data, the Oxford-AstraZeneca vaccine has continuously been shown to have an acceptable safety ...